Arg21

Site Information
VDHGVQIrFITEPVs SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 41554164
Available spectra: 1 CST

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 )
Disease tissue studied:	lung cancer ( 1 ) , non-small cell lung cancer ( 1 , 2 ) , non-small cell lung adenocarcinoma ( 1 ) , non-small cell large cell lung carcinoma ( 1 )
Relevant cell line - cell type - tissue:	HCC78 (pulmonary) ( 1 ) , lung ( 1 ) , NCI-H1781 (pulmonary) ( 1 ) , NCI-H2228 (pulmonary) ( 1 ) , NCI-H3122 (pulmonary) ( 1 , 2 ) , NCI-H661 (pulmonary) ( 1 )

References
1	Rikova K (2013) CST Curation Set: 20100; Year: 2013; Biosample/Treatment: cell line, H2228, H3122, HCC78, H661, H1781; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Antibodies Used to Purify Peptides prior to LCMS: Mono-Methyl Arginine [mme-R] MultiMab(TM) Rabbit mAb mix Cat#: 8015 Curated Info
2	Rikova K (2013) CST Curation Set: 18851; Year: 2013; Biosample/Treatment: cell line, H3122/crizotinib, geldanamycin; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Antibodies Used to Purify Peptides prior to LCMS: Mono-Methyl Arginine [mme-R] MultiMab(TM) Rabbit mAb mix Cat#: 8015 Curated Info